Pseudobulbar Affect: Identify & Manage
Psychiatry Education Forum Academy’s Coffee Club contains short discussions with clinical experts in the field of psychiatry. Coffee Club’s goal is to get answers for clinically relevant questions in short (~15 minutes) discussion videos so that you can learn and enjoy coffee during your coffee break.
Today we are excited to announce our next coffee club discussion with our guest expert speaker:
PSEUDOBULBAR AFFECT: LEARN TO IDENTIFY & MANAGE
Appropriate identification and subsequent management of Pseudobulbar affect (PBA) is clinically important in psychiatry as it can be misdiagnosed as treatment-resistant MDD, PTSD, Bipolar disorder, or borderline/histrionic personality, to name a few.
Dr. William Sauve will discuss this clinically relevant topic in the following sections:
- PBA Definition: using old and new criteria’s
- Why diagnosing PBA matter?
- PBA: Underlying pathology.
- Which screening scale to use for evaluation for PBA?
- PBA Treatment: on and off-label options.
- Emerging treatment/future directions for PBA treatment.
SCHEDULED RELEASE DATE: MAY 1, 2021
(ONLY FOR ACADEMY MEMBERS)
INTERESTED IN LEARNING MORE?
JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP
Why Join ACADEMY MEMBERSHIP?
This is a closed membership for medical professionals only.
- 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice.
- Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
- Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
- Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections.
- Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
- Conference Discounts: Academy members get discounted access at our conferences.
- Goal: is to have all important clinically relevant topics in one place for ease of access.
SUBSCRIBE TO OUR EMAIL NEWSLETTER:
